Interferon-Tau has Antiproliferative effects, represses the expression of E6 and E7 oncogenes, induces apoptosis in cell lines transformed with HPV16 and inhibits tumor growth in vivo

Journal of Cancer

Volumn 7, Issue 15, 2016, Pages 2231-2240

  Padilla Quirarte, Herbey Oswaldo ^a   Trejo Moreno, Cesar ^a   Fierros Zarate, Geny ^a   Castañeda, Jhoseline Carnalla ^a   Palma Irizarry, Marie ^a   Hernández Márquez, Eva ^a   Burguete Garcia, Ana Isabel ^a   Peralta Zaragoza, Oscar ^a   Madrid Marina, Vicente ^a   Torres Poveda, Kirvis ^a   Bermúdez Morales, Victor Hugo ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Human papillomavirus; IFN ; Immunotherapy; Oncogenes

Indexed keywords

ANTINEOPLASTIC AGENT; BETA INTERFERON; INTERFERON RECEPTOR; TAU INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VIVO STUDY; NONHUMAN; ONCOGENE; ONCOGENE E6; ONCOGENE E7; SIHA CELL LINE;

EID: 85030227003     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/JCA.15502     Document Type: Article

References (37)

1. Imakawa K. Anthony RV, Kazemi M, et al.: Interferon-like sequence of ovine tropho-blast protein secreted by embryonic trophectoderm. Nature 1987;330:377-379
2. Sen GC: Viruses and interferons. Annu Rev Microbiol 2001;55:255-281
3. Roberts RM, Liu L, Alexenko A. New and atypical families of Type 1 interferons in mammals: comparative functions, structures, and evolutionary relationships. Prog Nucleic Acid Res Mol Biol 1997;56:287-325
4. Chelmonskasoyta A. Interferon tau and its immunobiological role in ruminant reproduction. Arch Immuno Ther Exp (Warsz) 2002;50:47-52
5. Pontzer CH, Torres BA, Vallet JL, et al. Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1. Biochem Biophys Res Commun 1988;152:801-807
6. Pontzer CH, Bazer FW, Johnson HM: Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res 1991;51:5304-5307
7. Pontzer CH, Yamamoto JK, Bazer FW: Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau. J Immunol 1997; 158:4351-4357
8. Chon DT, Bixler S: Interferon-t: Current Applications and Potential in Antiviral Therapy. J Interferon Cytokine Res 2010;30:477-485
9. Song G, Han JH, Spencer TE, Bazer Z: Interferon Tau in ovine uterus. J Anim Sci Technol 2009;51:471-484
10. Choi Y, Johnson GA, Spencer TE, Bazer FW: Pregnancy and interferon tau regulate major histocompatibility complex class I and beta2-microglobulin expression in the ovine uterus. Biol Reprod 2003;68:1703-1710
11. Johnson FW, Ott HM, Pontzer TL, Van Heeke C. Antitumor therapy using ovine or bovine interferon-tau. 1999. US 5958402 A
12. Baker GE, Tyring SK: Therapeutic approaches to papillomavirus infections. Dermatol Clin 1997;15:331-40
13. Bonnez W, Oakes D, Bailey-Farchione A: A randomized double-blind trial of parenteral low dose versus high dose interferon-β in combination with cryotherapy for treatment of condyloma acuminatum. Antiviral Res 1997;35:41-52
14. Khan MA, Tolleson WH, Gangemi JD, et al.: Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alphainterferons. J Virol 1993;67(6): 3396-3403
15. Chiantore MV, Mangino G, Iuliano M, et al.: IFN-β antiproliferative effect and miRNA regulation in Human Papilloma Virus E6-and E7-transformed keratinocytes. Cytokine 2015; S1043-4666:30127-7
16. Zhang J, Li S, Yan Q, et al. Interferon-β induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells. PLoS One. 2013:16;e81366
17. Bermúdez VH, Peralta O, Guzmán E: HPV 16 E2 protein induces apoptosis in human and murine HPV 16 transformed epithelial cells and has antitumoral effects in vivo. Tumour Biol 2009;30:61-72
18. Crook T, Almond N, Murray A, et al: Constitutive expression of c-myc oncogene confers hormone independence and enhanced growth-factorresponsiveness on cells transformed by human papillomavirus type 16. Proc Natl Acad Sci USA 1989;86:5173-5717
19. Lin FC, Young HA: Interferons: Success in anti-viral immunotherapy. Cytokine Growth Factor Rev 2014;25:369-376
20. El-Baky NA, Redwan EM: Therapeutic alpha-interferons protein: structure, production, and biosimilar. Prep Biochem Biotechnol 2015;45:109-127
21. Agarwal C, Hembree JR, Rorke EA, Eckert RL: Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes. Cancer Res 1994;54:2108-2112
22. Kim KY, Blatt L, Taylor MW: The effects of interferon on the expression of human papillomavirus oncogenes. J Gen Virol 2000;81:695-700
23. Borden EC, Hogan TF, Voelkel JG: Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells. Cancer Res 1982;42:4948-4953
24. Johnson JA, Hochkeppel HK, Gangemi JD: IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression. J Interferon Cytokine Res 1999;19:1107-1116
25. Zé G, di Marco S, Mouchele E: Domains of interaction between alpha interferon and its receptor components. J Mol Biol 1994;243:245-257
26. Goodwin EC, DiMario D: Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderlyreactication of dormant tumor suppressor pathways. Proc Natl Acad Sci U S A. 2000;97:12513-12518
27. Wang B, Goff AK: Interferon-tau stimulates secretion of macrophage migration inhibitory factor from bovine endometrial epithelial cells. Biol Reprod 2003:1690-1696
28. Emond V, Asselin E, Fortier MA: Inteferon-tau stimulates granulocytes-macrophage colony-stimulating factor gene expression in bovine lymphocytes and endometrials stromal cells. Biol Reprod 2000;62: 1728-1737
29. Yankey SJ, Hicks BA, Carnahan KG: Expression of the antiviral protein MX in peripheral blood mononuclear cells of pregnant and bred, non-pregnant ewes. J Endocrinol 2001;170:R7-R11
30. Bagaoka K, Sakai A, Nojima A: A chemokine interferon (IFN)-gamma-inducible protein 10 kDa is stimulated by IFN-tau and recruits immune cells in the ovine endometrium. Biol Reprod 2003;68:1413-1421
31. Taslimi Y, Zahedifard F, Habibzadeh S, et al.: Antitumor effect of IP-10 by using two different approaches: Live delivery system and gene therapy. J Breast Cancer 2016;19:34-44
32. Kurbacher CM, Kurbacher JA, Cramer EM, et al.: Continuous low-dose GM-CSF as salvage therapy in refractory recurrent. Oncol 2000;4:23-26
33. Weiss AJ, Lackman RD: A comparison of human G-CSF and human GM-CSF given concurrently with anti-cancer chemotherapy. Oncol Rep 2002;9:945-950
34. Chang DZ, Lomazow W, Joy Somberg C, et al: Granulocyte-macrophage colony stimulating factor: An adjuvant for cancer vaccines. Hematol 2004;9:207-215
35. Basak SK, Harui A, Stolina M, et al: Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood 2002;99:2869-2879
36. Pinedo HM, Buter J, Luykx-de Bakker SA, et al: Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: Effect on tumour-draining lymph node dendritic cells. Eur J Cancer 2003;39:1061-1067
37. Qui Y, Moyana T, Chen Y, et al. Characterization of anti-tumor immunity derived from the inoculation of myeloma cells secreting the fusion protein RMA/IFN-tau. Hum Antibodies Hybrodomas 1996;7:21-26